Journal article · Vestibular← The news desk

✦ The Dispatch

Neurotransmitter regulatory networks in persistent postural-perceptual dizziness: potential mechanisms and therapeutic implications

A dispatch from PubMed — filed

Persistent postural-perceptual dizziness (PPPD) is a chronic functional vestibular disorder characterized by persistent non-spinning dizziness, subjective unsteadiness, and symptom exacerbation induced by upright posture, movement, and complex visual motion....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

Clinical Takeaway

No actionable change at this time — this is a mechanistic review; clinicians should monitor emerging pharmacological targets but no new treatment protocols are supported yet.

Why It Matters

Understanding the neurotransmitter networks behind PPPD could open new pharmacological avenues for a condition that is notoriously difficult to treat and commonly seen in vestibular clinics.

Key Points
  1. 01PPPD is a chronic functional vestibular disorder characterized by persistent dizziness and postural instability.
  2. 02The review maps neurotransmitter regulatory networks (e.g., serotonin, GABA, norepinephrine) implicated in PPPD.
  3. 03Disrupted sensory reweighting and maladaptive neural plasticity are proposed as core mechanisms.
  4. 04Therapeutic implications include potential roles for SSRIs/SNRIs and vestibular rehabilitation targeting these networks.
  5. 05No clinical trial data is presented; findings are mechanistic and theoretical.
Claims & Evidence

Neurotransmitter dysregulation is a central mechanism underlying PPPD symptoms.

opinionpartially supported

Targeting specific neurotransmitter pathways may offer therapeutic benefit in PPPD.

opinionunclear
Research metadata
PMID
42775155
DOI
10.3389/fneur.2026.1921702.
Journal
Frontiers in Neurology
Publication type
review
Evidence level
5
Population
Not applicable — narrative/mechanistic review of PPPD literature
Intervention
Review of neurotransmitter regulatory networks in PPPD

Primary outcomes

Characterisation of neurotransmitter pathways implicated in PPPD; Identification of potential therapeutic targets

Related stories